During this webinar, Dr. Gail Roboz from Weill Cornell, discuss the advances in MDS and AML research that was reported at the annual conferences of two major...

During this webinar, Dr. Phillip Scheinberg from Hospital Sao Jose, Beneficencia Portuguesa de Sao Paolo in Brazil will discuss the history of Aplastic Anemia - past,...

During this webinar, Dr. Michael Burke from Children's Hospital of Wisconsin, will discuss refractory/relapsed AML, how it is diagnosed, affects on treatments and...

During this webinar, Dr. Pamela Becker from Seattle Cancer Care Alliance and University of Washington School of Medicine will discuss the history of MDS - past,...

During this webinar, Dr. Shalmaya Navada from Tisch Cancer Institute will discuss the history of PNH - past, current and future thinking of the disease and treatment...

In this webinar, Dr. Elie Traer from OHSU Knight Cancer Institute in Portland, OR will discuss what is refractory/relapsed AML, how is it diagnosed, affects on...

In this webinar, Dr. Marlise Luskin from Dana Farber Cancer Institute will define high-risk MDS versus low-risk MDS, impact for patients and what treatment options are...

In this webinar, Dr. Saurabh Chhabra from The Cancer Center at Froedtert Hospital in Wisconsin will discuss the latest advances in preventing and treating...

In this webinar, Dr. Melhem Solh from The Blood and Marrow Transplant Group of Georgia will discuss what is GVHD, how it is diagnosed, signs and symptoms, treatment...

In this webinar, Dr. Jonathon Cohen from Winship Cancer Institute of Emory University will discuss relapsed CLL- what causes patients to relapse and what treatments...

In this webinar, Dr. Timothy Pardee from Wake Forest Baptist Health will discuss the challenges associated with treating AML in older adults and what treatment...

In this webinar, Dr. Matthew Davids will discuss the advances in treating CLL.

In this webinar, Susan Berg from the Center for Shared Decision Making at Dartmouth - Hitchcock will explain what is shared decision making and how patients/caregivers...

In this webinar, Dr. Danielle Brander from Duke University Medical Center in NC will discuss what is chronic lymphocytic leukemia (CLL), how it is diagnosed and what...

In the webinar, Dr. Casey O'Connell from USC Norris Comprehensive Cancer Center will help patients understand the most commonly used lab tests to diagnosis and monitor...

In this webinar, Dr. Thomas DeLoughery from Oregon Health Sciences University (OHSU) will explain what is intravascular and extravascular hemolysis, symptoms,...

In the webinar, Dr. DiNardo will explain the different mutations found in AML and how mutations impact prognosis and affect treatment decisions.

In this webinar, Dr. Robert Means Jr. will discuss disease and treatment symptoms associated with PRCA and how those symptoms are treated. He will also provide an...

During this webinar, Dr. Jamile Shammo from Rush University Medical Center, will discuss PNH and special concerns for women.

In this webinar, Dr. Amer Zeidan from Yale Cancer Center will explain the different mutations found in MDS. He will discuss how mutations impact prognosis and affect...

In this webinar, Dr. Daniel Pollyea from University of Colorado, will discuss the recent advances in treating AML.

In this webinar, Dr. Thomas Leblanc from Duke University Hospital will discuss AML - how the diagnosis and treatment decisions impact patients. He will also provide a...

During this program, registered oncology dietitian, Joanna Myers-Casale from MD Anderson Cancer Center at Cooper will discuss the most current recommendations for a...

During this program, Dr. Kasiani Myers of The Cancer and Blood Diseases Institute in Cincinnati, OH will discuss the causes, diagnosis and treatment of aplastic anemia...

In this webinar, Dr. Matt Kalaycio will explain what is a bone marrow transplant and the risk and benefits of a transplant for MDS patients. Patients will be able to...